Skip to main content
. Author manuscript; available in PMC: 2023 Aug 29.
Published in final edited form as: J Thorac Oncol. 2022 Nov 15;18(3):313–323. doi: 10.1016/j.jtho.2022.10.020

Table 5.

Mortality Hazard Ratios (With 95% CI and p Values) of Lung Cancer-Specific Survival and Nonlung Cancer Competing Causes of Death, by the Presence or Absence of Lung Cancer Resection

Adjusted Hazard Ratios (95% CI) of Cause-Specific Death by Resected vs. Unresected; p Value

Cause of Death Stage IA Stages IB-IIIA

[n] [1260] [2646]
Death from lung cancer 0.38 (0.28–0.52), p < 0.001 0.37 (0.32–0.42), p < 0.001
Death from other causes 1.73 (1.07–1.78), p = 0.02 1.18 (0.86–1.63), p = 0.31

Note: Separate analyses were performed for all stages and for individual disease stages at the time of diagnosis. Each analysis was adjusted for age, sex, race, education, smoking status, stage (except for stage IA), and study sites.

CI, confidence interval.